Follow-up of Patients With Previous SARS-CoV-2 Infection: Long-term Damage Assessment
1 other identifier
observational
100
1 country
2
Brief Summary
People affected by SARS-CoV-2 infection, whether patients have developed mild forms or a severe form of the disease, complain of nonspecific and entirely new symptoms or complain about the persistence pf them.Investigators intend to follow over time the post-infectious phase of patients discharged from sub-intensive care unit. The aim is to identify symptoms and their frequency of presentation in the SARS-CoV-2 population in the post-acute period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2021
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2022
CompletedFirst Submitted
Initial submission to the registry
April 27, 2022
CompletedFirst Posted
Study publicly available on registry
May 3, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2024
CompletedDecember 5, 2023
November 1, 2023
1 year
April 27, 2022
November 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Greater understanding of SARS-CoV-2 disease
Greater understanding of SARS-CoV-2 disease and its long-term manifestations. To this end, the clinical manifestations, any alterations in laboratory and instrumental parameters will be evaluated to identify organ damages and calculate its prevalence
24 months
Secondary Outcomes (1)
Measurement of psychological impact of SARS-CoV-2 disease
24 months
Study Arms (2)
Post-COVID patients
Patients recovered from Sars-CoV2 infection
healthy control patients
Patients who did not have Sars-CoV2
Interventions
Eligibility Criteria
Patients admitted to Ospedale San Salvatore dell'Aquila over 18 years during Sars-CoV2 pandemics, with or without Sars-CoV2 related disease
You may qualify if:
- Patients over 18
You may not qualify if:
- Patients under 18
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Clara Balsano
L’Aquila, Italy/L'Aquila, 67100, Italy
University of L'Aquila
L’Aquila, 67100, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full professor
Study Record Dates
First Submitted
April 27, 2022
First Posted
May 3, 2022
Study Start
February 1, 2021
Primary Completion
February 1, 2022
Study Completion
February 1, 2024
Last Updated
December 5, 2023
Record last verified: 2023-11